Preclinical biotech developing small molecule protein degraders for cancer and other diseases.
Industry: Health Care
Latest Trade: $6.48 0.00 (0.0%)
First Day Return: +11.5%
Return from IPO: -65.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/04/2021 |
Offer Price | $19.00 |
Price Range $17.00 - $19.00 | |
Offer Shares (mm) | 11.7 |
Deal Size ($mm) | $222 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/23/2021 |
Offer Price | $19.00 |
Price Range $17.00 - $19.00 | |
Offer Shares (mm) | 11.7 |
Deal Size ($mm) | $222 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
TD Cowen |
more |
Company Data | |
---|---|
Headquarters | Boston, MA, United States |
Founded | 2019 |
Employees at IPO | 74 |
Website www.monterosatx.com |